BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Treatment
850 results:

  • 1. 'It's not meant to be for life, but it carries on': a qualitative investigation into the psychosocial needs of young retinoblastoma survivors.
    O'Donnell N; Phillips B; Morgan JE; Howell D
    BMJ Open; 2024 Apr; 14(4):e082779. PubMed ID: 38688668
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Principles in the Management of Glioblastoma.
    Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Differences in Childhood Growth Parameters Between Patients With Somatic and Heritable Retinoblastoma.
    Hicks RM; Ji X; Zou Y; Sultana S; Rashid R; Sherief ST; Cassoux N; Garcia Leon JL; Diaz Coronado RY; López AMZ; Ushakova TL; Polyakov VG; Roy SR; Ahmad A; Reddy MA; Sagoo MS; Al Harby L; Berry JL; Polski A; Astbury NJ; Bascaran C; Blum S; Bowman R; Burton MJ; Gomel N; Keren-Froim N; Madgar S; Zondervan M; Kaliki S; Fabian ID; Stacey AW
    Invest Ophthalmol Vis Sci; 2024 Apr; 65(4):39. PubMed ID: 38662390
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Recent progress in retinoblastoma: Pathogenesis, presentation, diagnosis and management.
    Zhou M; Tang J; Fan J; Wen X; Shen J; Jia R; Chai P; Fan X
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100058. PubMed ID: 38615905
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
    Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
    Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Strabismus management in retinoblastoma survivors.
    Masoomian B; Shields CL; Esfahani HR; Khalili A; Ghassemi F; Rishi P; Akbari MR; Khorrami-Nejad M
    BMC Ophthalmol; 2024 Mar; 24(1):114. PubMed ID: 38481156
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Low expression of NR1D1 and NR2E3 is associated with advanced features of retinoblastoma.
    Ding J; Sun J; Ma RQ; Zheng K; Han YN
    Int Ophthalmol; 2024 Mar; 44(1):133. PubMed ID: 38480634
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Regulation of cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P cells.
    Pham TM; Ahmed M; Lai TH; Bahar ME; Hwang JS; Maulidi RF; Ngo QN; Kim DR
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474202
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Glioblastoma Therapy: Past, Present and Future.
    Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Diagnostic Imaging for Retinoblastoma Cancer Staging: Guide for Providing Essential Insights for Ophthalmologists and Oncologists.
    Pai V; Muthusami P; Ertl-Wagner B; Shroff MM; Parra-Fariñas C; Sainani K; Kletke S; Brundler MA; Mallipatna A
    Radiographics; 2024 Apr; 44(4):e230125. PubMed ID: 38451848
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characteristics of patients with recurrent retinoblastoma: a survival analysis.
    Li N; Wang YZ; Zhang Y; Zhang WL; Huang DS
    BMC Cancer; 2024 Mar; 24(1):287. PubMed ID: 38438837
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Management of Recurrence in Retinoblastoma Based on the Source of tumor cells.
    Thaker SK; Shah PK; Das A; Maitra P
    Middle East Afr J Ophthalmol; 2023; 30(1):24-30. PubMed ID: 38435107
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. METTL14-Mediated m6a Modification of CDKN2A Promotes the Development of Retinoblastoma by Inhibiting the p53 Pathway.
    Chen J; Zeng B
    Crit Rev Immunol; 2024; 44(3):89-98. PubMed ID: 38421707
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3.
    Xie W; Shao Y; Bo Q; Li Z; Yu Q; Wang L; Wu G
    Mol Carcinog; 2024 May; 63(5):926-937. PubMed ID: 38380957
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic and epigenetic features of neuroendocrine prostate cancer and their emerging applications.
    Zhang X; Barnett E; Smith J; Wilkinson E; Subramaniam RM; Zarrabi A; Rodger EJ; Chatterjee A
    Int Rev Cell Mol Biol; 2024; 383():41-66. PubMed ID: 38359970
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Circulating tumor DNA Posttreatment Measurements and Clinical Correlates in Retinoblastoma.
    Abramson DH; Robbins MA; Gobin YP; Dunkel IJ; Francis JH
    JAMA Ophthalmol; 2024 Mar; 142(3):257-261. PubMed ID: 38300595
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Traces of Dysregulated lncRNAs-Associated ceRNA Axes in Retinoblastoma: A Systematic Scope Review.
    Shahraki K; Najafi A; Ilkhani Pak V; Shahraki K; Ghasemi Boroumand P; Sheervalilou R
    Curr Eye Res; 2024 Jun; 49(6):551-564. PubMed ID: 38299506
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. When the second comes first- rhabdomyosarcoma preceding heritable retinoblastoma- a case report.
    Tripathy D; Moulin A; Bijon J; Gengler C; Beck-Popovic M; Munier FL; Stathopoulos C
    BMC Ophthalmol; 2024 Jan; 24(1):47. PubMed ID: 38291358
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Inhibition of Autophagy Aggravates
    Tsai CH; Huang HC; Lin KJ; Liu JM; Chen GL; Yeh YH; Lu TL; Lin HW; Lu MT; Chu PC
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279345
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Global retinoblastoma studies: A review.
    Vempuluru VS; Maniar A; Kaliki S
    Clin Exp Ophthalmol; 2024 Apr; 52(3):334-354. PubMed ID: 38263682
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 43.